[en] We have previously shown that C1q is expressed on endothelial cells (ECs) of newly formed decidual tissue. Here we demonstrate that C1q is deposited in wound-healing skin in the absence of C4 and C3 and that C1q mRNA is locally expressed as revealed by real-time PCR and in situ hybridization. C1q was found to induce permeability of the EC monolayer, to stimulate EC proliferation and migration, and to promote tube formation and sprouting of new vessels in a rat aortic ring assay. Using a murine model of wound healing we observed that vessel formation was defective in C1qa(-/-) mice and was restored to normal after local application of C1q. The mean vessel density of wound-healing tissue and the healed wound area were significantly increased in C1q-treated rats. On the basis of these results we suggest that C1q may represent a valuable therapeutic agent that can be used to treat chronic ulcers or other pathological conditions in which angiogenesis is impaired, such as myocardial ischemia.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Bossi, Fleur
Tripodo, Claudio
Rizzi, Lucia
Bulla, Roberta
Agostinis, Chiara
Guarnotta, Carla
Munaut, Carine ; Université de Liège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Folkman J (2003) Fundamental concepts of the angiogenic process. Curr Mol Med 3(7):643-651. (Pubitemid 37236406)
Sato Y (2012) The vasohibin family: Novel regulators of angiogenesis. Vascul Pharmacol 56(5-6):262-266.
Raza A, Franklin MJ, Dudek AZ (2010) Pericytes and vessel maturation during tumor angiogenesis and metastasis. Am J Hematol 85(8):593-598.
Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438(7070): 932-936. (Pubitemid 43093958)
Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146(5):1029-1039.
Chung AS, Ferrara N (2011) Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27:563-584.
Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473(7347):298-307.
Semenza GL (2007) Vasculogenesis, angiogenesis, and arteriogenesis: Mechanisms of blood vessel formation and remodeling. J Cell Biochem 102(4):840-847. (Pubitemid 350036924)
Fischetti F, Tedesco F (2006) Cross-talk between the complement system and endothelial cells in physiologic conditions and in vascular diseases. Autoimmunity 39(5):417-428. (Pubitemid 44269620)
Johnson LV, Leitner WP, Staples MK, Anderson DH (2001) Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res 73(6):887-896. (Pubitemid 34112114)
Nozaki M, et al. (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci USA 103(7):2328-2333. (Pubitemid 43271669)
Bora PS, et al. (2005) Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J Immunol 174(1):491-497. (Pubitemid 40007439)
Bora NS, et al. (2006) Complement activation via alternative pathway is critical in the development of laser-induced choroidal neovascularization: Role of factor B and factor H. J Immunol 177(3):1872-1878. (Pubitemid 44092526)
Bora NS, et al. (2007) CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration. J Immunol 178(3):1783-1790. (Pubitemid 46154650)
Langer HF, et al. (2010) Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 116(22):4395-4403.
Nayak A, Pednekar L, Reid KB, Kishore U (2012) Complement and non-complement activating functions of C1q: A prototypical innate immune molecule. Innate Immun 18(2):350-363.
Nayak A, Ferluga J, Tsolaki AG, Kishore U (2010) The non-classical functions of the classical complement pathway recognition subcomponent C1q. Immunol Lett 131(2): 139-150.
Feng X, Tonnesen MG, Peerschke EI, Ghebrehiwet B (2002) Cooperation of C1q receptors and integrins in C1q-mediated endothelial cell adhesion and spreading. J Immunol 168(5):2441-2448. (Pubitemid 34171848)
van den Berg RH, Faber-Krol MC, Sim RB, Daha MR (1998) The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J Immunol 161(12):6924-6930. (Pubitemid 28562239)
Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM (2001) The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 166(5):3231-3239. (Pubitemid 33117322)
Benoit ME, Tenner AJ (2011) Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci 31(9):3459-3469.
Bulla R, et al. (2008) Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium. Mol Immunol 45(9):2629-2640.
Kevil CG, Payne DK, Mire E, Alexander JS (1998) Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 273(24):15099-15103. (Pubitemid 28272806)
Dvorak HF (1986) Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315(26):1650-1659. (Pubitemid 17052899)
Kurihara R, et al. (2010) C5a promotes migration, proliferation, and vessel formation in endothelial cells. Inflamm Res 59(8):659-666.
Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE (2006) Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med 203(9):2165-2175. (Pubitemid 44352237)
Lee RJ, et al. (2000) VEGF gene delivery to myocardium: Deleterious effects of unregulated expression. Circulation 102(8):898-901.
